Dengue Fever Testing Market Size 2022-2027, Analysis by Industry Share, Growth, Report and Forecast
The latest research studyDengue Fever Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027by IMARC Group, finds that the Global dengue fever testing market size reached a value of US$522.6 million in 2021. Looking ahead, IMARC Group expects the market to reach a value of US$726.34 million by 2027, presenting a CAGR of 5.40% during the period 2022-2027.
Industry definition and application:
Dengue or bone-breaking fever is a viral infection that is spread by the bite of an infected Aedes aegypti mosquito. This causes headaches; muscle, bone and joint pain; high fever; abdominal pain; vomiting, pain behind the eyes; swollen glands; difficulty breathing; slight bleeding from the nose and gums; and skin rashes. It is diagnosed using dengue fever tests, including RT-PCR, dengue IgG/IgM rapid tests, and enzyme immunoassay (ELISA), which healthcare professionals perform to identify the different serotypes dengue virus and whether the patient is infected with dengue virus or not.
Impact of Covid-19:
We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Request a free sample PDF for more detailed market information: https://www.imarcgroup.com/dengue-testing-market/requestsample
Dengue Fever Testing Market Trends and Drivers:
The market is mainly driven by the increasing number of dengue fever cases due to changing climatic conditions and poor sanitation, which leads to breeding grounds for mosquitoes. For this reason, the governments of various countries are sensitizing the masses by educating them about the plight of dengue fever.
They also encourage people to prevent dengue through self-protection and thermal fogging of insecticides, which is another growth-inducing factor. Additionally, accurate diagnosis plays a crucial role in clinical care as it helps in epidemic control, case confirmation, vaccine development, pathogenesis, clinical trials, early detection of severe cases, academic research and differential diagnosis of other infectious diseases.
These benefits are accelerating the demand for dengue test kits globally. Other factors, including rapid urbanization, advances in the healthcare industry, and heavy investment by manufacturers in research and development (R&D) activities to create a highly effective and cost-effective dengue test kit, also contribute. to market growth.
|Market size value in 2021||US$522.6 million|
|Market forecast in 2027||US$726.34 million|
|Rate of growth||CAGR of 5.40% from 2022 to 2027|
|Base year for the estimate||2021|
Analysis and segmentation of the global dengue fever testing market 2022-2027:
The competitive landscape of the market has been studied in the report with the detailed profiles of the major players operating in the market.
Abbott Laboratories, Abnova Corporation, CerTest Biotec SL, DiaSorin SpA, F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.
The report has segmented the market based on region, test type, and end user.
Breakdown by type of test:
• ELISA-based tests
• Tests based on RT-PCR
• Dengue fever IgG/IgM rapid test
Breakdown by end user:
• Diagnostic centers
Breakdown by region:
• North America: (United States, Canada)
• Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa
Ask the analyst to customize and explore the full report with table of contents and list of figures: https://www.imarcgroup.com/dengue-testing-market
If you want the latest primary and secondary data (2022-2027) with cost module, business strategy, distribution channel, etc. Click request a free sample report, the published report will be emailed to you in PDF format within 24-48 hours of receipt. full payment.
Main highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market drivers and success factors
• SWOT analysis
• Value chain
• Complete mapping of the competitive landscape
If you need specific information that is not currently covered in the report, we can provide it to you as part of the customization.
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, Wyoming 82801 USA – Wyoming
E-mail: [email protected]
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800